Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma-Reference-Cited by-同舟云学术

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Published:2019-06-25 Issue:9 Volume:98 Page:2139-2150
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Spicka Ivan,Ocio Enrique M.,Oakervee Heather E.,Greil Richard,Banh Raymond H.,Huang Shang-Yi,D’Rozario James M.,Dimopoulos Meletios A.,Martínez Sara,Extremera Sonia,Kahatt Carmen,Alfaro Vicente,Carella Angelo M.,Meuleman Nathalie,Hájek Roman,Symeonidis Argiris,Min Chang-Ki,Cannell Paul,Ludwig Heinz,Sonneveld Pieter,Mateos María Victoria

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03739-2.pdf

Reference24 articles.

1. Kumar SK, Lee JH, Lahuerta JJ, Morgan G, Richardson PG, Crowley J, Haessler J, Feather J, Hoering A, Moreau P, LeLeu X, Hulin C, Klein SK, Sonneveld P, Siegel D, Blade J, Goldschmidt H, Jagannath S, Miguel JS, Orlowski R, Palumbo A, Sezer O, Rajkumar SV, Durie BG, International Myeloma Working G (2012) Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia 26(1):149–157. https://doi.org/10.1038/leu.2011.196

2. Anderson KC, Kyle RA, Rajkumar SV, Stewart AK, Weber D, Richardson P, Myeloma AFPCEM (2008) Clinically relevant end points and new drug approvals for myeloma. Leukemia 22(2):231–239. https://doi.org/10.1038/sj.leu.2405016

3. Cuadrado A, Garcia-Fernandez LF, Gonzalez L, Suarez Y, Losada A, Alcaide V, Martinez T, Fernandez-Sousa JM, Sanchez-Puelles JM, Munoz A (2003) Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK. J Biol Chem 278(1):241–250. https://doi.org/10.1074/jbc.M201010200

4. Cuadrado A, Gonzalez L, Suarez Y, Martinez T, Munoz A (2004) JNK activation is critical for Aplidin-induced apoptosis. Oncogene 23(27):4673–4680. https://doi.org/10.1038/sj.onc.1207636

5. Losada A, Munoz-Alonso MJ, Garcia C, Sanchez-Murcia PA, Martinez-Leal JF, Dominguez JM, Lillo MP, Gago F, Galmarini CM (2016) Translation elongation factor eEF1A2 is a novel anticancer target for the marine natural product plitidepsin. Sci Rep 6:35100. https://doi.org/10.1038/srep35100

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Multiple Myeloma Drug Efficacy;2024-08-08

2. Marine-Derived Bioactive Proteins and Peptides: A Review of Current Knowledge on Anticancer Potentials, Clinical Trials, and Future Prospects;Natural Product Communications;2024-03

3. Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies;Marine Drugs;2024-02-28

4. Drug from Marine Sampling to Factory;Marine Ecology: Current and Future Developments;2023-11-02

5. A review on marine source as anticancer agents;Journal of Asian Natural Products Research;2023-09-07